The life science and pharmaceutical industry has been one of the most active M&A sectors in the last few years. The panel, consisting of experienced in-house and outside counsels, will identify and discuss the motivations behind the deals, the typical value drivers of target companies, the specific challenges M&A practitioners encounter in this sector and how to address them with state-of-the-art solutions.
Paul Cronheim De Brauw Blackstone Westbroek, Amsterdam
Andreas Bohrer Group Ceneral Counsel, Lonza AG, Basel
Ben Gaffikin McCann Fitzgerald, Dublin
Matthias Hentzen Hengeler Müller, Düsseldorf